Appropriate Use of Dopamine Agonists and Levodopa in Restless Legs Syndrome in an Ambulatory Care Setting

Ogochukwu Chidozie Molokwu, PharmD


The Annals of Pharmacotherapy. 2008;42(5):627-632. 

In This Article


This study demonstrates that the majority of patients with RLS at Community Medical Centers were receiving levodopa rather than FDA-approved dopamine agonists. Chronic use of levodopa could lead to augmentation and rebound of RLS. The findings of this study confirm the need for education of providers on the appropriate use of levodopa and dopamine agonists in patients with RLS.

CLICK HERE for more information about this journal.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.